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Summary
Objective: To compare the efficacy of medical and surgical treatment for refractory
mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE).
Methods: A prospective controlled non-randomized study of 26 patients with MTLE who
underwent surgical treatment and 75 patients with MTLE who underwent medical
treatment between August 2002 andOctober 2004. All patients failed to achieve seizure
control with at least two first line antiepileptic drugs (AED) for partial seizures before
entering the study. We used Kaplan—Meier survival analyses as a function of time of
seizure recurrence to obtain estimates of 95% confident interval of seizure freedom and
log-rank test to compare the status of seizure control between the two groups.
Results: The cumulative proportion of patients free of all seizures (Engel’s class IA) was
higher in the surgical group (73%) compared to the clinical group (12%) (p < 0.0001). In
the surgical group, 2 of 26 patients (7.7%) had transient adverse effects and 2 of 26
patients (7.7%) had a permanent deficit related to the surgical procedure. In the clinical
group 7 patients (9.3%) major adverse events during follow-up, including burns and
status epilepticus.
Conclusions: Surgical treatment for patients with MTLE who failed to achieve seizure
control with two previous AED regimenswasmore efficient thanmedical treatmentwith
further trials of AED.
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Epilepsy affects between 0.5 and 2% of the general
population.1—5 The accumulated urban prevalence
in Brazil was recently estimated in 18.6/1000 inha-
bitants.6 It is the second most frequent neurological
condition,7 and its worldwide burden is compared to
that of breast cancer in women and lung cancer in
men.7—9 Epileptic syndromes presenting with partial
seizures account for 50—70% of all epilepsies and are
refractory to adequate drug therapy3,7 in approxi-
mately 60% of these patients.2,3,10,11 Surgery for
intractable focal epilepsy has been proposed for
more than a century,12 and more recent technolo-
gical advances have made possible to expand the
number of patients who may benefit from sur-
gery.12—17 The overall rate of significant improve-
ment with the surgery for temporal lobe epilepsy
(TLE) is 91—93.6%,18,19 but the rate of patients free
of seizures is lower, varying from 63 to 77%.9,18—21
Despite the good results with low rates of com-
plications,9,22—26 surgery is still underused, particu-
larly in developing countries. One of the reasons for
this is probably related to the lack of studies con-
firming the safety and efficacy of surgery as com-
pared to multiple trials of antiepileptic drugs (AEDs)
and the failure of primary care physicians on iden-
tifying the possible candidates.9 For most patients
who failed to achieve seizure control after first-line
AEDs, surgery is still considered the last resort,
being offered late in life, rendering psychosocial
rehabilitation unlikely.22
In this study, we compared the rates of seizure
freedom between medical and surgical treatment in
patients with mesial temporal lobe epilepsy asso-
ciated with hippocampal sclerosis (MTLE) who have
failed to obtain seizure control with at least two AED
regimens.Methods
This is a prospective controlled non-randomized
study designed to compare patients with refractory
MTLE submitted to medical and surgical treatment
at the Epilepsy Service of State University of Cam-
pinas, Brazil. We consecutively included all the
patients with diagnosis of MTLE with MRI evidence
of hippocampal sclerosis seen at the outpatient
clinic for refractory epilepsy at our institution,
during the period between August 2002 and October
2004, who fulfilled the following criteria: older than
12 years of age, clinical and EEG features of MTLE,11
failure of seizure control with at least two AED
regimens and seizure frequency at least one seizure
per month over the year before entry in the study.We excluded patients with any additional progres-
sive disease, such as malignancy or neurodegenera-
tive disorders and those with previous epilepsy
surgery.
Patients were explained that participation in this
study would not interfere with their medical treat-
ment orwith the possibility of surgical treatment and
that they could withdraw from the study at any time.
They underwent our routine outpatient investiga-
tion, including electroencephalography (EEG), mag-
netic resonance imaging (MRI) (T1-weighted axial,
coronal and sagittal, proton-density, T2-weighted
and fluid-attenuated inversion recovery sequences),
neuropsychological and psychological assessments.
Some patients with unclear origin of ictal discharges
were admitted to the hospital for video-EEG and ictal
SPECTwhen necessary before surgery.
Clinical and surgical groups
The clinical group consisted of all patients included
in the study while they were waiting for completing
their pre-surgical investigation, or waiting for sur-
gical procedure after having completed their pre-
surgical investigation, as well as those who rejected
the surgical treatment for personal reasons, includ-
ing religious aspects and fear of complications.
Apart from the personal rejection, they had no other
different risk factors and they were all equally
considered surgical candidates.
The surgical group consisted of all refractory
MTLE patients who were operated during the study
period.
Patients from both groups were explained to
complete a seizure calendar. The descriptions of
events were examined by at least two epileptolo-
gists who reached a consensus to classify as a seizure
or not.
Interventions
Three experienced neurosurgeons performed the
selective transsylvian amygdalohippocampect-
omy.27 We recorded the details of each surgery
and also all the per operative complications. After
surgery they received standard post-operative care
and were instructed to maintain the same AEDs
dosage used before for at least one year, even if
they were free of seizures. They were followed
monthly during the first 3 months, every 2 months
until 6 months and every 4 months after 6 months.
During this follow-up the epileptologists took into
account individual requirements, including correc-
tion of serum electrolytes and adjustments of the
dosage of AEDs in order to avoid side effects.
The clinical group has been followed since the
baseline with clinical visitations every 2—4 months.
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line AED different from the ones used before base-
line, or a combination of AED (polytherapy). For
these patients the epileptologists made the neces-
sary and appropriated AED adjustments and combi-
nations, according to individual maximal tolerance.
We made telephone calls for patients who missed
the visits.
Patients from both groups were instructed to
return for unscheduled visits or contact us by tele-
phone in case of any unexpected side effect, acci-
dent, or increase in seizure frequency.
Statistical analysis
We used T-test and paired T-test and to analyze
differences of continuous variables between groups
and Pearson x2 and Fisher exact tests to analyze
frequency distribution. To compare the status of
seizure control between the two groups we used
Kaplan—Meier event-free survival analyses to obtain
estimates of 95% confident intervals of seizure free-
dom and log-rank test to compare the results
between the two groups. We chose the Kaplan—
Meier method of analysis because it is an appropri-
ate method to compare the performances of dif-
ferent procedures in short-term analysis. This
method permits us to include in the same analysis
individuals with variations in follow-up duration
and also those individuals who did not experience
the outcome event during the period of study.
We chose the Mantel log-rank test to compare the
results from the survival distribution and to confirmTable 1 Characteristics of patients
Variable Clinical group
Age (years) at the study entry 39.5  9.3
Age (years) at the onset of seizures 10.6  9.8
Male/Female 35%/65%
History of status epilepticus 4%
Duration of follow-up (months)
Mean 12.7
Range 3—24
Monthly seizure frequency in the year
before the entrance in the
study (mean  S.D.)
6.8  9.6
Monthly seizure frequency at the last
follow-up (mean  SD)
8.0  18.3
Intragroup comparisons between entrance
and last follow-up
Not significan
( p = 0.40)
Accidents (burns, falls with head injury)
during the follow up
5.3%
Plus-minus values are means  S.D.that the differences were greater than expected by
chance.19,28Results
We studied 101 consecutive patients from our Epi-
lepsy’s Clinic, according to our inclusion criteria
described above. There were 75 patients in the
clinical group and 26 patients in the surgical group.
Before the baseline, there were no significant dif-
ferences between the two groups in terms of gender
distribution ( p = 0.91), age ( p = 0.13), antecedent
of previous status epilepticus ( p = 0.71) or acci-
dents during the follow-up ( p = 0.54), including
burns and falls with head injury. At the baseline of
the study, patients from the surgical group showed
an earlier onset of seizures in life (6.1  5.3) com-
pared to the clinical group (10.6  9.8) (p = 0.03).
The monthly average seizure frequency in the year
before the baseline was significantly higher in the
surgical group than in the clinical group (p = 0.001)
(Table 1).
Themean follow-up (range)was 12.7 (range 2—24)
months for the surgical group and 12.7 (range 3—24)
months for the clinical group (p = 0.96).
In the surgical group all the 26 patients under-
went transsylvian selective amygdalohippocam-
pectomy (16 on the left and 10 on the right
side). In 15 patients surgery was decided on the
basis of unilateral EEG discharges on serial routine
and prolonged EEG, coincident with ipsilateral(N = 75) Surgical group (N = 26) Statistics
36.2  9.4 T-test; p = 0.13
6.1  5.3 T-test; p = 0.03
38.5%/61.5% Yates corrected
x2; p = 0.91
— Fisher’s exact
test; p = 0.57
12.7 T-test; p = 0.96
2—24
29.2  57.5 T-test; p = 0.001
2.4  8.1 T-test; p = 0.13
t Significant
( p = 0.02)
Paired T-test with
Bonferroni adjusted
probability
_ Fisher’s exact test;
p = 0.57
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Figure 1 Kaplan—Meier event-free survival curves com-
paring the cumulative percentages of patients in the two
groups who were free of seizures. In the surgical group
more patients were free of seizure (P < 0.0001 by the log-
rank test).hippocampal atrophy and memory dysfunction on
neuropsychological evaluation.29 In 11 patients in
whom interictal epileptiform discharges were
scarce or who had bitemporal interictal discharges
we performed video-EEG for recording seizures
and ictal SPECT when necessary. None of these
patients required invasive investigation with intra-
cranial EEG recording.30,31 Eleven of 15 (73.3%)
patients who did not have video-EEG monitoring
became seizure free and 8 of 11 (72.7%) patients
who underwent video-EEG monitoring became sei-
zure free ( p = 1.0). Overall, 19 of 26 (73.1%)
operated patients were seizure free (Engel I-A),
5 of 26 (19.2%) improved (Engel Ib-II) and 2 of
26 (7.7%) remained with disabling seizures (Engel
III-IV).
Two of the 26 (7.7%) operated patients had tran-
sient complications related to the surgical proce-
dure: one had a post-operative small epidural
hematoma which was operated on and she recov-
ered without sequel; and one patient had a infection
in the surgical wound which was treated success-
fully. Two of the 26 (7.7%) patients had complica-
tions related to the surgical procedure which lead to
permanent deficits: one had thrombophlebitis of the
right central retinal vein and artery which led to
amaurosis of the right eye; and one patient pre-
sented mild memory deficits without compromising
his daily life.
In the clinical group 7 of the 75 (9.3%) patients
had significant complications related to seizures
during the follow-up: two had severe (second and
third degree) burns; two had falls with head injury,
and 3 had status epilepticus (Table 1). No neurolo-
gical deficits occurred in the clinical group. No
patients were lost to follow-up or died during the
period of the study.
It was necessary to switch the AEDs doses or
combinations in 35 patients of the clinical group
(47%), with the doses adjusted to maximal tolerated
doses. After surgery we needed to lower the AEDs
doses in 12 of 26 (46%) patients due to the side
effects, most commonly excessive somnolence, diz-
ziness and diplopia. In the surgical group we needed
to increase the AEDs doses in only 4 of 26 (15%)
patients due to persistent seizures after the surgery.
In the remaining patients from the surgical group,
the AEDs were maintained in the same dosage as
before surgery.
In the surgical group the average monthly sei-
zure frequency after the surgery (2.4  8.1) was
significantly lower than the average monthly sei-
zure frequency in the year before the surgery
(29.2  57.5) ( p = 0.02). In the clinical group,
the average of monthly seizure frequency
(6.8  9.6) over the year before the study wasnot different as compared to that of at the last
follow-up (8.0  18.2) ( p = 0.41). Nine of the 75
(12%) patients in the clinical group became seizure
free during the study period, and 7 (9.3%) patients
had at least 50% reduction in seizure frequency.
Therefore, the overall improvement rate in the
clinical group was 21.3%.
The cumulative proportion of patients free of all
seizures (Engel’s class IA)18 was higher in the surgical
group with 19 of 26 patients (73.1%) compared to
the clinical group with 9 of 75 (12%) ( p < 0.0001)
(Fig. 1).Discussion
Our study confirms the efficacy and superiority of
surgical treatment to control seizures in patients
with MTLE, even in a country with limited resources.
The surgical treatment achieved a better rate of
success despite the higher frequency of seizures
registered during the year before the surgery. Our
rate of freedom of seizures during the study period
in the surgical group was of 73.1% versus 12% in
the clinical group. The overall improvement in the
surgical group (92.3% in Engel I + II) was also higher
than the improvement in the clinical group
(21.3% of patients with at least 50% reduction in
seizure frequency) in accordance with previous
studies.13,18,26,32—40
After surgery, some patients (46%) who were free
of seizures could not tolerate the side effects and
Comparison between surgical and clinical treatment in temporal lobe epilepsy 39this fact lead us to reduce their AEDs. A similar
situation was already reported by Griffin et al.41
Although surgical morbidity was relatively high,
with 2 of the 26 (7.7%) patients having permanent
deficits, complications were also frequent in the
clinical group (9.3%)9,24—26,37,42,43
One limitation of our study, compared to that of
Wiebe et al.,9 is that our patients were not rando-
mized. However, our waiting list for surgical proce-
dures and for pre-surgical evaluation is quite long
due to the fact that our hospital serves a highly
dense populated area in a country with few centers
for epilepsy surgery. In addition, several of our
patients reject surgery for religious or cultural rea-
sons. These two factors allowed us to include pro-
spectively a series of patients in the clinical group
with similar characteristics and duration of follow-
up. In fact, our clinical group had almost three times
more patients than the surgical group, although all
were potentially surgical candidates. One of the
differences between groups at baseline was the
higher seizure frequency in the surgical group. This
indicates a bias towards more severe epilepsy in
the surgical group and would be in favor of a better
seizure outcome in the clinical group. However,
our results were in the opposite direction of this
potential bias.
Another issue that may be raised is that the
follow-up period varies widely within both groups,
although it is similar between groups. This is
explained by the fact that patients entered in the
study at different time points during the period of
observation. For example, a patient that entered in
the beginning of the study had 24 months of follow-
up and another patient that entered two months
before the end of the study period had only 2months
of follow-up. In addition, the duration of seizure
free intervals during the study period also varied
widely among patients. In statistics, this is called
‘‘progressive censored observations’’.28 Fortu-
nately, the Kaplan—Meier survival analyses is a
robust and appropriate method for analyzing pro-
gressive censored observations even in a relatively
small number of patients when there are no con-
founding variables.28
In this study, the surgical treatment proved to be
superior to medical treatment in terms of seizure
control in a short-term follow-up.9,18,34 Prolonged
treatment with AEDs does not offer good chances of
seizure relief and does not preclude social and
physical disability. The overall improvement in
terms of seizure control with the surgical treatment
may offer new perspectives for these patients with
refractory MTLE regarding social rehabilitation,
improvement in quality of life and even in employ-
ment status.9,13References
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